This model successfully recapitulates multiple hallmark pathological features of ALS, including a distinct dyskinesia phenotype, global TDP‐43 pathology, MN degeneration, gliosis, severe muscle atrophy with fibrosis, TMEM106B accumulation, and increased SOD1 and APOE4 levels. Here, TMEM106B is linked to drug-induced dyskinesia.